Back to today’s briefing

Story perspectives

New Sleep Drug Shows Promise Against Alzheimer's Damage

5/30/2025

22 4

Summary

Story summary

A groundbreaking study from Washington University reveals that lemborexant, a sleep medication approved by the FDA, could shield against Alzheimer’s-related brain damage. In mice, it significantly reduced toxic tau protein accumulation and boosted hippocampal volume by 30-40%. While these findings are hopeful, more research is essential to explore its impact on humans and neurodegenerative disease prevention.

1 of 1

Story summary

A groundbreaking study from Washington University reveals that lemborexant, a sleep medication approved by the FDA, could shield against Alzheimer’s-related brain damage. In mice, it significantly reduced toxic tau protein accumulation and boosted hippocampal volume by 30-40%. While these findings are hopeful, more research is essential to explore its impact on humans and neurodegenerative disease prevention.